Regenerative Medicine

February 4, 2019

Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment

October 10, 2018
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX

Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX

September 12, 2018

The Future of BioManufacturing: Automated Closed Systems for Cell & Gene Therapy Processes

July 12, 2018
Global Drug Development IPOs: NASDAQ Dominance Continues as 26 Companies Raise Over $2.54B in Q2

Global Drug Development IPOs: NASDAQ Dominance Continues as 26 Companies Raise Over $2.54B in Q2

June 4, 2018

The Future of BioManufacturing: In Silico Modelling

April 12, 2018
Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

February 20, 2018
2018 Global Drug Development IPO Review

2018 Global Drug Development IPO Analysis: $10.24B Raised in Strongest Year on Record

January 30, 2018
GLOBAL DRUG DEVELOPMENT IPOs: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017

Global Therapeutic IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017

October 5, 2017
Slow Quarter for the Global Therapeutic IPO Market: 13 Companies Raise Over $1B in Q3 2017

2017 Global Therapeutic IPO Market: 121% YOY Increase in Funds Raised Despite Slow Q3

Contact Us